Buy or sell seres therapeutics stock? The rating firms predict current quarter revenue for seres therapeutics inc.
From ai system, total return is 3107.67% from 2797 forecasts.
Seres therapeutics stock prediction. Is $14.04, and for 2030 nov. (nasdaq:mcrb) were traded, and its beta was 3.68. You'll find the seres therapeutics share forecasts, stock quote and buy / sell signals below.according to present data seres therapeutics's mcrb shares and potentially its market environment have been in.
View the latest ratings for mcrb. The stock's open price was 9.67. According to the issued ratings of 7 analysts in the last year, the consensus rating for seres therapeutics stock is buy based on the current 1 sell rating, 1 hold rating and 5 buy ratings for mcrb.
Seres therapeutics' current and average target prices are 8.67 and 22.83, respectively. The prediction is based on 9 analyst estimates. , and has now gained 8 days in a row.it is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected.
Is $12.33, for 2026 nov. The average seres therapeutics stock price prediction forecasts a potential downside of n/a from the current mcrb share price of $9.17. Seres therapeutics inc stock forecast.
And changed its name to seres therapeutics, inc. For the last reported quarter, it was expected that seres therapeutics would post a loss of $0.41 per share when it actually produced a loss of $0.53, delivering a surprise of. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2021 revenue estimates.
Over the next 52 weeks, seres therapeutics inc has on average historically risen by 63.3 % based on the past 6 years of stock performance. Analyst estimates, including mcrb earnings per share estimates and analyst recommendations. However, investors should pay attention to other factors too for betting on this stock or staying away from it.
Based on mcrb analyst price targets, mcrb stock forecast is $20.57 (for a year from now). 187 rows seres therapeutics (mcrb) stock price prediction is 12.341996655533 usd. Is it worth investing in seres therapeutics inc.
Seres therapeutics inc () stock market info recommendations: On average, wall street analysts predict that. To see how seres therapeutics inc.
Is $6.97, for 2022 nov. Wall street stock market & finance report, prediction for the future: Seres therapeutics inc stock price forecast for further price development up to 1.09% (time horizon:
In the last trading session, 2.05 million shares of the seres therapeutics inc. On the other hand, seres therapeutics' target price is what analysts think the stock is worth or could sell for in the future. During the day the stock fluctuated 4.93% from a day low at $9.13 to a day high of $9.58.
Stock has been performing in comparison to its peers in the industry, here are the numbers: 1 day) and price target of 9.26 usd. 34 rows close price at the end of the last trading day (wednesday, 1st dec 2021).
The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe mcrb will outperform the market and that investors should add to their positions of seres therapeutics. The seres therapeutics stock price gained 0.11% on the last trading day (monday, 22nd nov 2021), rising from $9.16 to $9.17. Seres therapeutics inc has risen higher in 1 of those 6 years over the subsequent 52 week period, corresponding to a historical accuracy of 16.67 %
Was founded in 2010 and is headquartered in cambridge, massachusetts. This has resulted in an earnings esp of 0%.on the other hand, the stock currently carries a zacks rank of #3.so, this combination makes it difficult to conclusively predict that seres therapeutics. Seres therapeutics currently has 1 sell rating, 1 hold rating and 5 buy ratings from wall street analysts.
What is mcrb stock forecast (i.e., prediction)? That means the average analyst price target for mcrb stock is $20.57. Seres therapeutics's share price could stay at $20.83 by jul 23, 2022.
Get the latest seres therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including seres stock investment advice, charts, stats and more. Is $10.74, for 2025 nov. The low price target for mcrb is $7.00, while the high price.
The current price of seres therapeutics is the price at which seres therapeutics is currently trading. Most recently the company’s share price was $9.16, and it changed around $0.49 or 5.65% from the last close, which brings the market valuation of the company to $796.28 The company was formerly known as seres health, inc.